WINNETKA, Calif., April 24, 2014 /PRNewswire/ -- Triton
Distribution Systems, Inc. (OTC Pink: TTDZ) ("Triton") announced
today the entry into a strategic partnership with Hemjoba, Inc., a
California corporation that
produces and retails blended formulas of Jojoba oil and
cold-extracted Cannabis oils. Additionally, Triton provided updates
on certain corporate events.
Hemjoba Partnership
Since 2009, Hemjoba has strived to provide to the general public
medical cannabis products, which do not have the euphoria and mind
altering properties that have stigmatized the cannabis plant as a
"Gateway Drug." The strategic partnership between Triton and
Hemjoba will allow Allbotanical.com to become the exclusive on-line
retailer of Hemjoba Pain Relieving Lotion and Hemjoba Omega XL H3O
topical healing oil. At the same time, and with the assistance of
Richard Brumfield, Founder of
Hemjoba, Triton plans to develop additional product concepts for
the brand Green Magic, and explore additional medicinal product
concepts to be added to the brand Green Cures, which will be
introduced to the public throughout 2014.
"Our primary goal is to offer a wide range of products through
our first online e-commerce platform Allbotanical.com, which
features products that do not require any medical prescription or
recommendation," said Triton's CEO Robert
Calkin. The Company's initial strategy of producing an
immediate generating income resource will bring a platform
(Allbotanical.com) that offers numerous hemp-based nutritional and
body care products, as well as safe alternatives to narcotic
medications with formulations of cold-extracted Cannabis oils (Hemp
and Sativa), which omits the THC or the cannabinoids that produce
the "high" associated with Cannabis (marijuana).
Corporate Updates
In addition, the Company announced to the public and the
investment community that management anticipates that
Allbotanical.com will start processing orders within the next 5
business days. Currently, the Company is finalizing imaging
applications and details about its logistics department to ensure
that all customers receive their orders through an expedited mail
delivery system.
The Company also announced to the public and the investment
community that it has submitted the Company's Annual Report for the
year ending December 31, 2013, along
with other required disclosures, to the OTC Markets website.
Finally, the Company announced to the investment community that
in connection with the Company's efforts to change the name of the
Company, management anticipates receiving stamped Articles of
Incorporation from the time that the company began using its
current name, Triton Distribution Systems Inc., from the state of
Colorado within the upcoming week.
This document is required to submit a completed application
to request the change of company's name to FINRA, with the
assistance of the Company's legal counsel and professional
advisors.
In closing, management of the Company anticipates that the
Company will provide additional updates to the public and the
investment community when material events and information becomes
available.
About Triton Distribution Systems
Inc.: www.greencuresinc.com Triton operates a diverse
portfolio of services and products within the botanical industry
and medical cannabis industry, as permitted by law. The products
include nutritional supplements, vitamins, minerals,
herbs/botanicals, sports nutrition, and specialty. In this
rapidly growing industry of alternative care and medicinal
products, Triton Distribution Systems Inc. also provides to the
online community portals that supply with information and resources
regarding the benefits of cannabis-derived products..
About Hemjoba Inc: www.buyhemjoba.com Hemjoba Inc. Since 2009
Hemjoba has provided medical cannabis products to the general
public without the euphoria and mind altering properties that have
stigmatized the cannabis plant as a "Gateway Drug". The company's
goal is to provide products that offer a safe alternative to
narcotic medications that have become an epidemic of dependency and
addiction over the last 25 years.
FDA Statement: The statements contained in this document have
not been evaluated or approved by the FDA. The products and
statements referenced in this document are not intended to
diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain
certain forward-looking statements and information, as defined
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material
contains statements about expected future events and/or financial
results that are forward-looking in nature and subject to risks and
uncertainties. Forward-looking statements are identified by wording
such as "scheduled (future sense)" "intend(s)", "plan(s)"
"expect(s)", "believe(s)" "will" "estimate(s)", "forecast",
"anticipate(s)", "expect(s)", "may", "should", "goal", "target",
"aim", "may", "would", "could" or "should" or, in each case, the
negative thereof, other variations thereon, comparable terminology
or wording/graphical information that implies anticipated future
results or deliverables. Investors are cautioned that such
forward-looking statements involve risks and uncertainties,
including, without limitation, progress of products development,
acceptance of products, increased levels of competition, new
products and technological changes, dependence upon third-party
suppliers, and intellectual property rights. You are cautioned not
to place any undue reliance on any forward-looking statement, and
Triton expressly disclaims any obligation or intention to update
any forward-looking statement.
SOURCE Triton Distribution Systems, Inc.